Vascular Pharmacology of Epoxyeicosatrienoic Acids
- 14 November 2010
- book chapter
- review article
- Published by Elsevier BV
- Vol. 60, 27-59
- https://doi.org/10.1016/b978-0-12-385061-4.00002-7
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Epoxyeicosanoid signaling in CNS function and diseaseProstaglandins & Other Lipid Mediators, 2010
- Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine modelBiochemical Pharmacology, 2010
- Epoxyeicosatrienoic acids and endothelium-dependent responsesPflügers Archiv - European Journal of Physiology, 2010
- Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationJournal of Molecular and Cellular Cardiology, 2009
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase InhibitionJournal of Medicinal Chemistry, 2009
- Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto–Kakizaki ratsClinical Science, 2008
- Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP‐9 via inhibition of NF‐κβ in hyperhomocysteinemiaJournal of Cellular Physiology, 2008
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980